home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Regulating Embryonic Stem Cell Self-Renewal

  October, 18 2007 5:15
your information resource in human molecular genetics
In the October 15th issue of Genes & Development, Dr. Huck-Hui Ng and colleagues at the Genome Institute of Singapore identify two genes ­ called Jmjd1a and Jmjd2c ­ that regulate self-renewal in embryonic stem cells. This finding will have important ramifications for embryonic stem cell research.

“These are new pathways that the ES cell uses to counteract inappropriate silencing of key pluripotency genes. Perturbation of these pathways affects the maintenance of ES cells," explains Dr. Ng.

Embryonic stem cells (ES cells) are pluripotent: They can differentiate into any of the specialized cell types of the body (excluding the placenta), as well as new, undifferentiated (unspecialized) stem cells (a process known as “self-renewal”). Understanding the genetic basis of self-renewal is integral to the long-term maintenance of viable ES cell lines.

Dr. Ng and colleagues investigated how modifications to chromatin structure influence gene transcription and ES cell function. The researchers found that Jmjd1a and Jmjd2c, which encode enzymes that demethylate histone H3 lysine 9, regulate self-renewal in mouse ES cells: Depletion of Jmjd1a and Jmjd2c promoted differentiation, at the expense of self-renewal. Thus, these two histone modifying enzymes are required for maintaining pluripotency of ES cells.

Source: Genes & Development Press Release

Message posted by: Robin Kimmel

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.